CoChat
Sign Up
Cited by 87Neurological disorders and treatmentsParkinson's Disease Mechanisms and TreatmentsMotor Control and Adaptation

Transducer‐based evaluation of tremor

Open access
Haubenberger, Dietrich, Abbruzzese, Giovanni, Bain, Peter G., Bajaj, Nin, Benito‐León, Julián, Bhatia, Kailash P., Deuschl, Günther, Forjaz, Maria João +9 more·2016·Movement Disorders
DOI 10.1002/mds.26671PMC PMC5014626
Open this paper in CoChat — free account

Abstract

The International Parkinson and Movement Disorder Society established a task force on tremor that reviewed the use of transducer‐based measures in the quantification and characterization of tremor. Studies of accelerometry, electromyography, activity monitoring, gyroscopy, digitizing tablet‐based measures, vocal acoustic analysis, and several other transducer‐based methods were identified by searching PubMed.gov . The availability, use, acceptability, reliability, validity, and responsiveness were reviewed for each measure using the following criteria: (1) used in the assessment of tremor; (2) used in published studies by people other than the developers; and (3) adequate clinimetric testing. Accelerometry, gyroscopy, electromyography, and digitizing tablet‐based measures fulfilled all three criteria. Compared to rating scales, transducers are far more sensitive to changes in tremor amplitude and frequency, but they do not appear to be more capable of detecting a change that exceeds random variability in tremor amplitude (minimum detectable change). The use of transducer‐based measures requires careful attention to their limitations and validity in a particular clinical or research setting. © 2016 International Parkinson and Movement Disorder Society

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.26671

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tremor is well suited to spectral analysis, the most popular method of tremor quantification, because of its oscillatory characteristics.

    “Tremor is well suited to spectral analysis, the most popular method of tremor quantification, because of its oscillatory characteristics (113).”

    From A Review on Wearable Technologies for Tremor Suppression (2021) · cites this paper as [113]

    The Results sections on Accelerometry and Activity monitoring say spectral analysis is frequently used to estimate tremor amplitude and frequency and can distinguish oscillation from other movement. This supports its suitability for analyzing oscillatory tremor, but the paper does not establish that it is the most popular method of tremor quantification. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 92

  1. [1]Elble R Bain P Forjaz MJ Task force report: scales for screening and evaluating tremor: critique and recommendations Mov Disord 2013 28 13 1793 1800 24038576
  2. [2]Weir JP Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM J Strength Cond Res 2005 19 1 231 240 15705040
  3. [3]Elble RJ Hallett M Accelerometry Handbook of Clinical Neurophysiology 2003 New York Elsevier Science B. V. 181 190
  4. [4]Elble RJ Gravitational artifact in accelerometric measurements of tremor Clin Neurophysiol 2005 116 7 1638 1643 15905122
  5. [6]Marshall J Physiological tremor in children J Neurol Neurosurg Psychiatry 1959 22 33 35 13642074 PMC497345
  6. [7]Despres C Richer F Roberge MC Lamoureux D Beuter A Standardization of quantitative tests for preclinical detection of neuromotor dysfunctions in pediatric neurotoxicology Neurotoxicology 2005 26 3 385 395 15935210
  7. [8]Fusco C Valls-Sole J Iturriaga C Colomer J Fernandez-Alvarez E Electrophysiological approach to the study of essential tremor in children and adolescents Dev Med Child Neurol 2003 45 9 624 627 12948330
  8. [9]Elble RJ Deuschl G Brown WF Bolton CF Aminoff M Tremor Neuromuscular Function and Disease: Basic, Clinical and Electrodiagnostic Aspects 2002 Philadelphia W. B. Saunders Co 1759 1779
  9. [11]Elble RJ Higgins C Leffler K Hughes L Factors influencing the amplitude and frequency of essential tremor [published erratum appears in Mov Disord 1995 May;10(3):411] Mov Disord 1994 9 6 589 596 7845397
  10. [12]Elble RJ Characteristics of physiologic tremor in young and elderly adults Clin Neurophysiol 2003 114 4 624 635 12686271
  11. [13]Louis ED Pullman SL Comparison of clinical vs. electrophysiological methods of diagnosing of essential tremor Mov Disord 2001 16 4 668 673 11481690
  12. [14]Caligiuri MP Tripp RM A portable hand-held device for quantifying and standardizing tremor assessment J Med Eng Technol 2004 28 6 254 262 15513743
  13. [15]de Lima ER Andrade AO Pons JL Kyberd P Nasuto SJ Empirical mode decomposition: a novel technique for the study of tremor time series Med Biol Eng Comput 2006 44 7 569 582 16937193
  14. [16]Elble RJ Koller WC Tremor 1990 first Baltimore The Johns Hopkins University Press
  15. [17]Calzetti S Findley LJ Perucca E Richens A Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor J Neurol Neurosurg Psychiatry 1982 45 10 893 897 6815306 PMC491593
  16. [18]Mera T Vitek JL Alberts JL Giuffrida JP Kinematic optimization of deep brain stimulation across multiple motor symptoms in Parkinson’s disease J Neurosci Methods 2011 198 2 280 286 21459111 PMC3122330
  17. [19]Handforth A Martin FC Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor Mov Disord 2004 19 10 1215 1221 15390011
  18. [20]Haubenberger D McCrossin G Lungu C Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study Neurology 2013 80 10 933 940 23408867 PMC3653213
  19. [21]Gorman WP Cooper R Pocock P Campbell MJ A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis J Neurol Neurosurg Psychiatry 1986 49 1 64 68 3514797 PMC1028650
  20. [22]Schwingenschuh P Katschnig P Seiler S Moving toward “laboratory-supported” criteria for psychogenic tremor Mov Disord 2011 26 14 2509 2515 21956485 PMC3664413
  21. [23]Wastensson G Holmberg B Johnels B Barregard L Quantitative Methods for Evaluating the Efficacy of Thalamic Deep Brain Stimulation in Patients with Essential Tremor Tremor and Other Hyperkinetic Movements 2013 3 PMC3822146 24255800
  22. [24]Elble RJ Pullman SL Matsumoto JY Raethjen J Deuschl G Tintner R Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales Brain 2006 129 Pt 10 2660 2666 16891320
  23. [25]Voller B Lines E McCrossin G Alcohol challenge and sensitivity to change of the essential tremor rating assessment scale Mov Disord 2014 29 4 555 558 24123358 PMC4189108
  24. [26]Jeon H Kim SK Jeon B Park KS Distance estimation from acceleration for quantitative evaluation of Parkinson tremor IEEE Engineering in Medicine and Biology Society Conference 2011 2011 393 396 22254331
  25. [27]Mostile G Fekete R Giuffrida JP Amplitude fluctuations in essential tremor Parkinsonism Relat Disord 2012 18 7 859 863 22591578
  26. [28]Cleeves L Findley LJ Variability in amplitude of untreated essential tremor J Neurol Neurosurg Psychiatry 1987 50 704 708 3612150 PMC1032074
  27. [30]Bushara KO Malik T Exconde RE The effect of levetiracetam on essential tremor Neurology 2005 64 6 1078 1080 15781835
  28. [31]Gironell A Kulisevsky J Barbanoj M Lopez-Villegas D Hernandez G Pascual-Sedano B A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor Arch Neurol 1999 56 4 475 480 10199338
  29. [32]Koller WC Vetere-Overfield B Acute and chronic effects of propranolol and primidone in essential tremor Neurology 1989 39 12 1587 1588 2586774
  30. [33]Koller WC Dose-response relationship of propranolol in the treatment of essential tremor Arch Neurol 1986 43 1 42 43 3942513
  31. [34]Koller W Herbster G Cone S Clonidine in the treatment of essential tremor Mov Disord 1986 1 4 235 237 3332805
  32. [35]Koller WC Royse VL Time course of a single oral dose of propranolol in essential tremor Neurology 1985 35 10 1494 1498 4033931
  33. [36]Koller WC Propranolol therapy for essential tremor of the head Neurology 1984 34 8 1077 1079 6379505
  34. [37]Baruzzi A Procaccianti G Martinelli P Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial Neurology 1983 33 3 296 300 6338416
  35. [38]Kuroda Y Kakigi R Shibasaki H Treatment of essential tremor with arotinolol Neurology 1988 38 4 650 652 2451192
  36. [39]Papapetropoulos S Gallo BV Guevara A Objective tremor registration during DBS surgery for essential tremor Clin Neurol Neurosurg 2009 111 4 376 379 19121890
  37. [40]Jankovic J Schwartz K Clemence W Aswad A Mordaunt J A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor Mov Disord 1996 11 3 250 256 8723140
  38. [41]Ushe M Mink JW Revilla FJ Effect of stimulation frequency on tremor suppression in essential tremor Mov Disord 2004 19 10 1163 1168 15390071
  39. [42]Fox P Bain PG Glickman S Carroll C Zajicek J The effect of cannabis on tremor in patients with multiple sclerosis Neurology 2004 62 7 1105 1109 15079008
  40. [43]Koller WC Herbster G Adjuvant therapy of parkinsonian tremor Arch Neurol 1987 44 9 921 923 3619710
  41. [44]Obwegeser AA Uitti RJ Witte RJ Lucas JA Turk MF Wharen RE Jr Quantitative and qualitative outcome measures after thalamic deep brain stimulation to treat disabling tremors Neurosurgery 2001 48 2 274 281 discussion 281–274 11220369
  42. [45]Papapetropoulos S Jagid JR Sengun C Singer C Gallo BV Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease Neurology 2008 70 1244 1249 18391156
  43. [46]Sturman MM Vaillancourt DE Metman LV Bakay RA Corcos DM Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson’s disease Brain 2004 127 Pt 9 2131 2143 15240437
  44. [47]Popa T Russo M Vidailhet M Cerebellar rTMS stimulation may induce prolonged clinical benefits in essential tremor, and subjacent changes in functional connectivity: an open label trial Brain stimulation 2013 6 2 175 179 22609238
  45. [48]Shill HA Bushara KO Mari Z Reich M Hallett M Open-label dose-escalation study of oral 1-octanol in patients with essential tremor Neurology 2004 62 12 2320 2322 15210907
  46. [49]Lorenz D Hagen K Ufer M Cascorbi I Deuschl G Volkmann J No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study Neurology 2006 66 11 1753 1755 16769957
  47. [50]Zesiewicz TA Ward CL Hauser RA Sanchez-Ramos J Staffetti JF Sullivan KL A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor Mov Disord 2006 22 279 282 17149715
  48. [52]Milner-Brown HS Stein RB The relation between the surface electromyogram and muscular force J Physiol 1975 246 3 549 569 1133787 PMC1309435
  49. [53]Boose A Spieker S Jentgens C Dichgans J Wrist tremor: investigation of agonist-antagonist interaction by means of long-term EMG recording and cross-spectral analysis Electroencephalogr Clin Neurophysiol 1996 101 355 363 8761046
  50. [54]Scholz E Bacher M Diener HC Dichgans J Twenty-four-hour tremor recordings in the evaluation of the treatment of Parkinson’s disease J Neurol 1988 235 8 475 484 3210053
  51. [55]Spieker S Boose A Breit S Dichgans J Long-term measurement of tremor Mov Disord 1998 13 Suppl 3 81 84 9827600
  52. [56]Spieker S Ströle V Sailer A Boose A Dichgans J Validity of long-term electromyography in the quantification of tremor Mov Disord 1997 12 6 985 991 9399225
  53. [57]Pogarell O Gasser T van Hilten JJ Pramipexole in patients with Parkinson’s disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study J Neurol Neurosurg Psychiatry 2002 72 6 713 720 12023411 PMC1737934
  54. [58]Spieker S Jentgens C Boose A Dichgans J Reliability, specificity and sensitivity of long-term tremor recordings Electroencephalogr Clin Neurophysiol 1995 97 326 331 8536582
  55. [59]Heldman DA Jankovic J Vaillancourt DE Prodoehl J Elble RJ Giuffrida JP Essential tremor quantification during activities of daily living Parkinsonism Relat Disord 2011 17 7 537 542 21570891 PMC3137659
  56. [60]Mostile G Giuffrida JP Adam OR Davidson A Jankovic J Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor Mov Disord 2010 25 12 1938 1943 20623687
  57. [61]Pulliam CL Eichenseer SR Goetz CG Continuous in-home monitoring of essential tremor Parkinsonism Relat Disord 2014 20 1 37 40 24126021 PMC3946846
  58. [62]Lambrecht S Gallego JA Rocon E Pons JL Automatic real-time monitoring and assessment of tremor parameters in the upper limb from orientation data Front Neurosci 2014 8 221 25120424 PMC4110507
  59. [65]Giuffrida JP Riley DE Maddux BN Heldman DA Clinically deployable Kinesia technology for automated tremor assessment Mov Disord 2009 24 5 723 730 19133661
  60. [66]van Someren EJW Vonk BFM Thijssen WA A new actigraph for long-term registration of the duration and intensity of tremor and movement IEEE Trans Biomed Eng 1998 45 3 386 395 9509754
  61. [67]Parees I Saifee TA Kassavetis P Believing is perceiving: mismatch between self-report and actigraphy in psychogenic tremor Brain 2012 135 Pt 1 117 123 22075068
  62. [69]van Someren EJ Pticek MD Speelman JD Schuurman PR Esselink R Swaab DF New actigraph for long-term tremor recording Mov Disord 2006 21 8 1136 1143 16639727
  63. [70]Hoff JI Wagemans EA van Hilten BJ Ambulatory objective assessment of tremor in Parkinson’s disease Clin Neuropharmacol 2001 24 5 280 283 11586112
  64. [71]Binder S Deuschl G Volkmann J Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy Eur Neurol 2009 61 3 149 153 19092251
  65. [72]Goetz CG Stebbins GT Wolff D Testing objective measures of motor impairment in early Parkinson’s disease: Feasibility study of an at-home testing device Mov Disord 2009 24 4 551 556 19086085 PMC4161502
  66. [73]Picillo M Moro E Edwards M Di Lazzaro V Lozano AM Fasano A Subdural Continuous Theta Burst Stimulation of the Motor Cortex in Essential Tremor Brain Stimul 2015 8 4 840 842 26038179
  67. [74]Nahab FB Wittevrongel L Ippolito D An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor Neurotherapeutics 2011 8 4 753 762 21594724 PMC3250299
  68. [75]Elble RJ Brilliant M Leffler K Higgins C Quantification of essential tremor in writing and drawing Mov Disord 1996 11 70 78 8771070
  69. [76]Elble RJ Sinha R Higgins C Quantification of tremor with a digitizing tablet J Neurosci Methods 1990 32 193 198 2385136
  70. [77]Rudzinska M Izworski A Banaszkiewicz K Bukowczan S Marona M Szczudlik A Quantitative tremor measurement with the computerized analysis of spiral drawing Neurol Neurochir Pol 2007 41 6 510 516 18224573
  71. [78]Zesiewicz TA Sullivan KL Hinson V Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor Mov Disord 2013 28 2 249 250 23238907
  72. [79]Elble RJ Lyons KE Pahwa R Levetiracetam is not effective for essential tremor Clin Neuropharmacol 2007 30 6 350 356 18090460
  73. [80]Haubenberger D Kalowitz D Nahab FB Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor Mov Disord 2011 26 11 2073 2080 21714004 PMC4117681
  74. [81]Shatunov A Sambuughin N Jankovic J Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23 Brain 2006 129 2318 2331 16702189
  75. [82]Hsu AW Piboolnurak PA Floyd AG Spiral analysis in Niemann-Pick disease type C Mov Disord 2009 24 13 1984 1990 19672994
  76. [83]Rudzinska M Krawczyk M Wojcik-Pedziwiatr M Szczudlik A Tomaszewski T Tremor in neurodegenerative ataxias, Huntington disease and tic disorder Neurol Neurochir Pol 2013 47 3 232 240 23821420
  77. [84]Hess CW Hsu AW Yu Q Ortega R Pullman SL Increased variability in spiral drawing in patients with functional (psychogenic) tremor Human movement science 2014 38 15 22 25240176
  78. [86]Feys P Helsen W Prinsmel A Ilsbroukx S Wang S Liu X Digitised spirography as an evaluation tool for intention tremor in multiple sclerosis J Neurosci Methods 2007 160 2 309 316 17113154
  79. [88]Adler CH Bansberg SF Hentz JG Botulinum toxin type A for treating voice tremor Arch Neurol 2004 61 9 1416 1420 15364688
  80. [89]Bové M Daamen N Rosen C Wang CC Sulica L Gartner-Schmidt J Development and validation of the vocal tremor scoring system Laryngoscope 2006 116 9 1662 1667 16955000
  81. [90]Busenbark K Ramig L Dromey C Koller WC Methazolamide for essential voice tremor Neurology 1996 47 5 1331 1332 8909454
  82. [91]Gamboa J Jimenez-Jimenez FJ Nieto A Acoustic voice analysis in patients with essential tremor J Voice 1998 12 4 444 452 9988031
  83. [92]Chenausky K Macauslan J Goldhor R Acoustic Analysis of PD Speech Parkinsons Dis 2011 2011 435232 21977333 PMC3185254
  84. [93]Schoentgen J Modulation frequency and modulation level owing to vocal microtremor The Journal of the Acoustical Society of America 2002 112 2 690 700 12186048
  85. [94]Buder EH Strand EA Quantitative and graphic acoustic analysis of phonatory modulations: the modulogram J Speech Lang Hear Res 2003 46 2 475 490 14700387
  86. [95]Lester RA Barkmeier-Kraemer J Story BH Physiologic and acoustic patterns of essential vocal tremor J Voice 2013 27 4 422 432 23490130
  87. [96]Shao J MacCallum JK Zhang Y Sprecher A Jiang JJ Acoustic analysis of the tremulous voice: assessing the utility of the correlation dimension and perturbation parameters J Commun Disord 2010 43 1 35 44 19909966 PMC2813418
  88. [97]Anand S Shrivastav R Wingate JM Chheda NN An acoustic-perceptual study of vocal tremor J Voice 2012 26 6 811 e811–817 22921293
  89. [98]Hertegard S Granqvist S Lindestad PA Botulinum toxin injections for essential voice tremor Ann Otol Rhinol Laryngol 2000 109 2 204 209 10685574
  90. [99]Warrick P Dromey C Irish JC Durkin L Pakiam A Lang A Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection Laryngoscope 2000 110 8 1366 1374 10942143
  91. [100]Cook CE Clinimetrics corner. The minimal clinically important change score (MCID): a necessary pretense J Man Manip Ther 2008 16 4 E82 E83 19771185 PMC2716157
  92. [101]Deuschl G Raethjen J Hellriegel H Elble R Treatment of patients with essential tremor Lancet Neurol 2011 10 2 148 161 21256454

Cited by

Sorted by citations

Authors
Haubenberger, D., Abbruzzese, G., Bain, P. G., Bajaj, N., Benito‐León, J., Bhatia, K. P., Deuschl, G., Forjaz, M. J., Hallett, M., Louis, E. D., Lyons, K. E., Mestre, T. A., Raethjen, J., Stamelou, M., Tan, E., Testa, C. M., & Elble, R. J.
Affiliations
  • National Institutes of Health (US)
  • University of Genoa (IT)
  • Charing Cross Hospital (GB)
  • Nottingham University Hospitals NHS Trust (GB)
  • Universidad Complutense de Madrid (ES)
  • National Hospital for Neurology and Neurosurgery (GB)
  • Christian-Albrechts-Universität zu Kiel (DE)
  • Instituto de Salud Carlos III (ES)
  • Yale University (US)
  • University of Kansas Medical Center (US)
  • University of Ottawa (CA)
  • Neurology Department University of Athens, Greece and Neurology Department, Philipps University Marburg Germany
  • National University of Singapore (SG)
  • Virginia Commonwealth University (US)
  • SIU Medicine (US)
Corresponding author
Haubenberger, Dietrich
ORCID
Venue
Movement Disorders
Publisher
Wiley
Published
2016-06-06
Volume
31
Issue
9
Pages
1327-1336
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
DOI
10.1002/mds.26671
PMC
PMC5014626
OpenAlex
W2412915795
Cited by
87
References
4
Citations by year
2026: 5 · 2025: 12 · 2024: 3 · 2023: 10 · 2022: 15 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 10 · 2017: 7 · 2016: 3
FWCI
1.25
Type
journal article
Language
en
Open access
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • Movement Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • National University of Singapore (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
The International Parkinson and Movement Disorders Society
Topics
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Motor Control and Adaptation
Keywords
tremor, accelerometry, electromyography, digitizing tablet, activity monitoring, tremor quantification, minimal detectable change, clinimetric properties, Parkinson's disease
MeSH terms
Humans, Transducers, Tremor, Diagnostic Techniques and Procedures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review